FUSCO, ALFREDO
 Distribuzione geografica
Continente #
AS - Asia 4.700
NA - Nord America 3.354
EU - Europa 1.113
SA - Sud America 984
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 8
Totale 10.315
Nazione #
US - Stati Uniti d'America 3.182
SG - Singapore 2.038
CN - Cina 1.032
BR - Brasile 760
HK - Hong Kong 498
VN - Vietnam 495
IT - Italia 337
FR - Francia 262
NL - Olanda 185
KR - Corea 183
BD - Bangladesh 120
CA - Canada 70
GB - Regno Unito 69
AR - Argentina 67
IN - India 62
DE - Germania 61
CO - Colombia 48
EC - Ecuador 48
ID - Indonesia 48
JP - Giappone 47
FI - Finlandia 43
MX - Messico 40
ZA - Sudafrica 25
VE - Venezuela 24
IL - Israele 22
PL - Polonia 20
SA - Arabia Saudita 20
ES - Italia 19
TR - Turchia 18
PK - Pakistan 17
UA - Ucraina 16
PH - Filippine 14
RU - Federazione Russa 14
MA - Marocco 13
PY - Paraguay 13
SE - Svezia 13
IQ - Iraq 12
PE - Perù 12
AT - Austria 10
JM - Giamaica 9
SC - Seychelles 9
TN - Tunisia 9
HN - Honduras 8
PA - Panama 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
CR - Costa Rica 7
KE - Kenya 7
LT - Lituania 7
NP - Nepal 7
UZ - Uzbekistan 7
AU - Australia 6
GR - Grecia 6
MY - Malesia 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
BB - Barbados 5
BG - Bulgaria 5
DZ - Algeria 5
EG - Egitto 5
LB - Libano 5
PS - Palestinian Territory 5
PT - Portogallo 5
SV - El Salvador 5
GT - Guatemala 4
IE - Irlanda 4
JO - Giordania 4
AZ - Azerbaigian 3
BE - Belgio 3
BY - Bielorussia 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
KW - Kuwait 3
KZ - Kazakistan 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
HU - Ungheria 2
IS - Islanda 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
Totale 10.225
Città #
Singapore 1.158
Santa Clara 780
Hong Kong 493
San Jose 478
Hefei 380
Ashburn 275
Beijing 217
Lauterbourg 215
Seoul 179
Ho Chi Minh City 175
Los Angeles 119
Hanoi 114
São Paulo 67
Naples 53
New York 53
Buffalo 52
Dallas 52
Helsinki 40
Frankfurt am Main 31
Da Nang 26
Chicago 25
Houston 24
Minamishinagawa 24
Rome 24
Milan 23
Orem 21
Phoenix 21
Rio de Janeiro 21
Tokyo 18
Brasília 17
Brooklyn 17
Atlanta 16
Belo Horizonte 16
Bengaluru 16
Guayaquil 16
London 16
Warsaw 16
Council Bluffs 15
Dhaka 15
Quito 14
Biên Hòa 13
Haiphong 13
Campinas 12
Curitiba 12
Queens 12
Stockholm 12
Hải Dương 11
Johannesburg 11
Philadelphia 11
Porto Alegre 11
Seattle 11
Amsterdam 10
Boardman 10
Bogotá 10
Düsseldorf 10
Las Vegas 10
Miami 10
Ninh Bình 10
Washington 10
Denver 9
Louisville 9
Ribeirão Preto 9
The Bronx 9
Bắc Giang 8
Cleveland 8
Falkenstein 8
Jacksonville 8
Medellín 8
Newark 8
Paris 8
Portsmouth 8
Turin 8
Asunción 7
Baghdad 7
Boston 7
Caracas 7
Chennai 7
Kingston 7
Lima 7
Madrid 7
Palermo 7
Piscataway 7
Poplar 7
Quận Bình Thạnh 7
Richmond 7
San José 7
Shanghai 7
Bari 6
Belém 6
Bologna 6
Caxias do Sul 6
Detroit 6
Jakarta 6
Jeddah 6
Lahore 6
Manchester 6
Mexico City 6
Milwaukee 6
Montreal 6
Phủ Lý 6
Totale 5.832
Nome #
HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. 94
Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas. 89
HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas 87
Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype 85
Suppression of transformation by inhibition of HMGI-C protein synthesis: regulatory changes of NF-kB and AP-1 transcription factors. 85
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation. 85
The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin. 82
HMGA1: a choice of symmetry 81
Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1 80
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. 80
High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs 79
POZ-, AT-hook-, and Zinc Finger-containing Protein (PATZ) Interacts with Human Oncogene B Cell Lymphoma 6 (BCL6) and Is Required for Its Negative Autoregulation 79
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 76
The b-catenin Axis Integrates Multiple Signals Downstream From RET/PTC and Leads to Cell Proliferation. 75
Characterization of inflammatory infiltrate of ulcerative dermatitis in C57BL/6NCrl-Tg(HMGA1P6)1Pg mice 75
Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer 73
HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity 73
The role of the suppressor genes and of HMGI proteins. 66
A differential proteomic approach to identify proteins associated with thyroid cell transformation 66
A ceRNA circuitry involving the long noncoding RNA KLHL14-AS, PAX8, and BCL2 drives thyroid carcinogenesis 66
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. 66
Identification and Synthesis of Mycalol Analogues with Improved Potency against Anaplastic Thyroid Carcinoma Cell Lines. 65
HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells 65
Oncogenic alterations in papillary thyroid cancers of young patients. 65
CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1 64
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. 63
Double knock-out of Hmga1 and Hipk2 genes causes perinatal death associated to respiratory distress and thyroid abnormalities in mice 62
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs 61
Oncogenic Properties of the Antisense lncRNA COMET in BRAF- and RET-Driven Papillary Thyroid Carcinomas 61
The metallophosphoesterase-domain-containing protein 2 (MPPED2) gene acts as tumor suppressor in breast cancer 60
HMGA1-pseudogene overexpression contributes to cancer progression 60
HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody. 59
Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice 59
In ataxia-teleangiectasia betamethasone response is inversely correlated to cerebellar atrophy and directly to antioxidative capacity. 58
High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-?-mediated transrepression in the vasculature. 58
Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity. 57
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene 57
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. Nanomedicine. 57
PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context 57
AP-1 compositional changes in transformed thyroid cells: role of fra-1 induction and functional interaction with the HMGI-C gene product. 56
Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype 56
Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. 56
Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage. 56
Tumour Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis. 56
HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma 56
The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression. 55
Regulation of microRNA expression by HMGA1 proteins. 55
HMGA2 cooperates with either p27 deficiency or Cdk4 mutation in pituitary tumorigenesis. 55
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma 55
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness 55
MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells 55
Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. 54
Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes 54
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive. 53
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 53
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation. 52
Critical role of the high mobility group A proteins in hematological malignancies 52
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 52
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 52
Characterization of HMGA1P6 transgenic mouse embryonic fibroblasts 51
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. 51
MIR191 (microRNA 191) 51
Critical role of HMGA proteins in cancer cell chemoresistance 51
HMGA and cancer: A review on patent literatures 51
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 51
Pax8 has a critical role in epithelial cell differentiaion, survival and proliferation. 51
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. 50
CBX7 is a tumor suppressor in mice and humans 50
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 50
Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays 50
HMGA1 negatively regulates NUMB expression at transcriptional and post transcriptional level in glioblastoma stem cells 50
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 50
Role of Dicer1 in thyroid cell proliferation and differentiation 50
The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism 50
The HMGA1-pseudogene7 shows oncogenic activity in vivo 49
HMGA1-pseudogene expression is induced in human pituitary tumors 49
The long non-coding RNA RP5-1024C24.1 and its associated-gene MPPED2 are down-regulated in human thyroid neoplasias and act as tumour suppressors 49
Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors. 49
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle 49
Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas 49
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. 49
PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription. 48
miR-142-3p Down-Regulation Contributes to Thyroid Follicular Tumorigenesis by Targeting ASH1L and MLL1 48
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. 48
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation. 48
Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin. 48
Deregulation of microRNA expression in thyroid neoplasias 47
Hmga1null mouse embryonic fibroblasts display downregulation of spindle assembly checkpoint gene expression associated to nuclear and karyotypic abnormalities 47
Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma 47
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype. 47
Identification and Characterization of a Novel RING-Finger Gene (RNF4) Mapping at 4p16.3 47
Let-7a Down-Regulation Plays a Role in Thyroid Neoplasias of Follicular Histotype Affecting Cell Adhesion and Migration through Its Ability to Target the FXYD5 (Dysadherin) Gene 47
miR-130b-3p Upregulation Contributes to the Development of Thyroid Adenomas Targeting CCDC6 Gene. 47
Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas. 47
HMGA1-pseudogene7 transgenic mice develop B cell lymphomas 46
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models. 46
CBX7 Modulates the Expression of Genes Critical for Cancer Progression 46
HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels. 46
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. 46
HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis Cell Cycle 46
Totale 5.810
Categoria #
all - tutte 36.116
article - articoli 32.930
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 351
Totale 69.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202462 0 0 0 0 0 0 0 0 13 1 40 8
2024/20253.413 18 15 309 136 673 122 89 162 132 246 813 698
2025/20265.515 255 515 546 894 1.105 206 716 259 265 249 213 292
2026/20271.325 297 288 740 0 0 0 0 0 0 0 0 0
Totale 10.315